ketanserin has been researched along with Diabetes Mellitus in 4 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 10.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
| "Ketanserin is a S2-serotonergic receptor antagonist with antihypertensive activity." | 6.66 | Ketanserin in the treatment of diabetes-associated hypertension. ( Beretta-Piccoli, C, 1988) |
| "The available data on the use of ketanserin in diabetes mellitus have been reviewed." | 6.16 | Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review. ( Janssens, M; Robertson, MP; Symoens, J, 1991) |
| "Ketanserin is a S2-serotonergic receptor antagonist with antihypertensive activity." | 2.66 | Ketanserin in the treatment of diabetes-associated hypertension. ( Beretta-Piccoli, C, 1988) |
| "Ketanserin was administered intravenously as a bolus of 10 mg over four minutes followed by a constant infusion at the rate of 5 mg/hr." | 1.27 | Effects of ketanserin, a 5-HT2-receptor antagonist, on the blood flow response to temperature changes in the diabetic foot. ( Apelian, A; Jageneau, AH; Khachadurian, AK; Schneider, SH; Tendler, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heimes, K | 1 |
| Feistel, B | 1 |
| Verspohl, EJ | 1 |
| Janssens, M | 1 |
| Symoens, J | 1 |
| Robertson, MP | 1 |
| Schneider, SH | 1 |
| Tendler, M | 1 |
| Apelian, A | 1 |
| Jageneau, AH | 1 |
| Khachadurian, AK | 1 |
| Beretta-Piccoli, C | 1 |
1 review available for ketanserin and Diabetes Mellitus
| Article | Year |
|---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
2 trials available for ketanserin and Diabetes Mellitus
| Article | Year |
|---|---|
Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus; Diabetic Angiopathies; Foot Ulcer; Humans; Hypertensi | 1991 |
Ketanserin in the treatment of diabetes-associated hypertension.
Topics: Adult; Aged; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Hemodynamics; Humans; | 1988 |
2 other studies available for ketanserin and Diabetes Mellitus
| Article | Year |
|---|---|
Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Guanidine; Indoles; Insulin; Insulin Sec | 2009 |
Effects of ketanserin, a 5-HT2-receptor antagonist, on the blood flow response to temperature changes in the diabetic foot.
Topics: Adult; Aged; Diabetes Mellitus; Female; Foot; Hemodynamics; Humans; Ketanserin; Male; Middle Aged; P | 1985 |